CytomX Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · South San Francisco, CA
CTMX chart
What traders are saying about $CTMX
Latest postsCytomX Therapeutics, Inc. news
- CytomX Therapeutics, Inc. Estimates – NASDAQ:CTMX
TradingView ·
- CytomX Therapeutics to Present at Upcoming September Investor Conferences
Yahoo Finance ·
- CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan (“Varseta-M”) for Relapsed/Refractory Metastatic Colorectal Cancer (R/R mCRC)
Yahoo Finance ·
- CytomX Therapeutics Inc (CTMX) (Q2 2026) Earnings Call Highlights: Varetta M Advances Toward ...
Yahoo Finance ·
- CytomX Therapeutics Q2 Earnings Call Highlights
marketbeat.com ·
- CytomX Therapeutics (CTMX) Reports Q2 Loss, Lags Revenue Estimates
Yahoo Finance ·
- CytomX Therapeutics Announces Q2 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- CytomX Therapeutics Appoints Alejandra Carvajal as Chief Legal Officer
Yahoo Finance ·
- CytomX Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026
Yahoo Finance ·
- CytomX Therapeutics Announces Appointment of Charles Fuchs, M.D., M.P.H., to the Board of Directors
Yahoo Finance ·
- CytomX Therapeutics (CTMX) Upgraded to Buy: Here's Why
Yahoo Finance ·
- Is CytomX (CTMX) One of the Best Growth Stocks Under $30 to Buy Now?
Yahoo Finance ·
CytomX Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $76.2M | $138.1M | $101.2M | $53.2M |
| Net income | -$17.4M | $31.9M | -$569,000 | -$99.3M |
| Total assets (year end) | $151.6M | $120.5M | $201.8M | $260.9M |
| Cash and equivalents (year end) | $12.7M | $38.1M | $17.2M | $193.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About CytomX Therapeutics, Inc.
- Ticker
- CTMX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- South San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1501989
Frequently asked questions
What exchange is CytomX Therapeutics, Inc. listed on?
CytomX Therapeutics, Inc. trades on the Nasdaq under the ticker symbol CTMX.
What industry is CytomX Therapeutics, Inc. in?
CytomX Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is CytomX Therapeutics, Inc. headquartered?
CytomX Therapeutics, Inc.'s business address on file with the SEC is in South San Francisco, CA.
When does CytomX Therapeutics, Inc.'s fiscal year end?
CytomX Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did CytomX Therapeutics, Inc. report?
CytomX Therapeutics, Inc. reported $76.2M in revenue for calendar year 2025, according to its SEC filings.